ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,007,000 | -80.3% | 71,500 | -57.9% | 0.56% | -42.0% |
Q4 2017 | $5,119,000 | -43.4% | 170,000 | -29.2% | 0.97% | -40.3% |
Q3 2017 | $9,041,000 | +29.7% | 240,000 | -4.0% | 1.62% | -16.9% |
Q2 2017 | $6,973,000 | -74.1% | 250,000 | -68.1% | 1.95% | -69.4% |
Q1 2017 | $26,911,000 | +211.0% | 782,756 | +160.9% | 6.38% | +98.3% |
Q4 2016 | $8,652,000 | +4.6% | 300,000 | +15.4% | 3.22% | +3.6% |
Q3 2016 | $8,270,000 | +196.2% | 260,000 | +202.3% | 3.11% | +131.4% |
Q2 2016 | $2,792,000 | – | 85,999 | – | 1.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |